Suppressed IgG4 Class Switching in Dupilumab- and TNF Inhibitor-Treated Patients after Repeated SARS-CoV-2 Mrna Vaccination
Anika M. Valk,Jim B.D. Keijser,Koos P.J. van Dam,Eileen W. Stalman,Luuk Wieske,Maurice Steenhuis,Laura Y.L. Kummer,Phyllis I. Spuls,Marcel W. Bekkenk,Annelie H. Musters,Nicoline F. Post,Angela L. Bosma,Barbara Horváth,DirkJan Hijnen,Corine R.G. Schreurs,Zoé L.E. van Kempen,Joep Killestein,Adriaan G. Volkers,Sander W. Tas,Laura Boekel,Gerrit J. Wolbink,Sofie Keijzer,Ninotska I.L. Derksen, Melanie van Deelen,Gerard van Mierlo,Taco W. Kuijpers,Filip Eftimov,S. Marieke van Ham,Anja ten Brinke,Theo Rispens, TB! Immunity against SARS-CoV-2 study group medRxiv（2023）
Key words
Immunoglobulin Replacement Therapy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper